Trapezius Botox, Barbie Botox and Traptox: What the Label Actually Says
Reviewed for medical accuracy against our Medical Review Board · Last updated 26 August 2026
Part of Botox by Facial Area
Trapezius Botox, sold online as "Barbie Botox" or "traptox", is injecting botulinum toxin into the shoulder muscle to soften the slope between neck and shoulder. It is not FDA approved for that. But the label does contain a trapezius dose, and knowing what it is changes how you read the doses being discussed online: it is 30 units, and it is there to prevent migraine.
This is off-label use of a drug whose label has unusually blunt warnings about injecting the neck. Both of those things can be true at once, and this page sets out what the label actually says so you can weigh it yourself.
1. What the treatment is
The upper trapezius runs from the base of the skull out to the shoulder. Relax it and the slope from neck to shoulder softens, which is the look the trend is after: a longer-looking neck and a squarer shoulder line. The same logic as masseter Botox for jaw slimming, applied to a much larger muscle.
Three names, one treatment. "Barbie Botox" and "traptox" are marketing terms; trapezius Botox is what it is. If you are comparing prices or providers, search all three, because clinics use them interchangeably.
Approval status, plainly. There is no FDA approval for injecting the trapezius to change its appearance. Botox is approved for chronic migraine, cervical dystonia, spasticity, hyperhidrosis and several other conditions, and cosmetically for the forehead, frown lines, crow's feet and platysma bands. Shoulder slimming is not on that list. Off-label prescribing is legal and routine, but you are entitled to be told that is what it is.
2. The one labelled trapezius dose
Here is what almost no coverage of this trend mentions. The trapezius does appear in the Botox label, with a specific dose, inside the chronic migraine protocol:
| Muscle area | Labelled dose |
|---|---|
| Frontalis | 20 units in 4 sites |
| Corrugator | 10 units in 2 sites |
| Procerus | 5 units in 1 site |
| Occipitalis | 30 units in 6 sites |
| Temporalis | 40 units in 8 sites |
| Trapezius | 30 units in 6 sites |
| Cervical paraspinal | 20 units in 4 sites |
| Total | 155 units in 31 sites, every 12 weeks |
Thirty units, split across six sites, distributed bilaterally, so fifteen units per side. That is the figure a regulator has looked at for this muscle. It exists to prevent headaches rather than to reshape a shoulder, and a cosmetic dose is a different judgement, but it is the only labelled anchor there is. If a dose you have been quoted is several times that, the honest position is that it sits well outside anything the label describes. Our units guide covers labelled doses by area, and the chronic migraine page covers this protocol in full.
3. Injecting this muscle is established, therapeutically
None of the above means trapezius injection is exotic. The label's cervical dystonia section reports which muscles were injected across 88 patients in the clinical programme:
| Muscle | Patients treated | Mean % of dose | Mid-range |
|---|---|---|---|
| Splenius capitis and cervicis | 83 | 38% | 25 to 50% |
| Sternocleidomastoid | 77 | 25% | 17 to 31% |
| Levator scapulae | 52 | 20% | 16 to 25% |
| Trapezius | 49 | 29% | 18 to 33% |
| Semispinalis | 16 | 21% | 13 to 25% |
| Scalene | 15 | 15% | 6 to 21% |
| Longissimus | 8 | 29% | 17 to 41% |
So the trapezius was injected in 49 of 88 patients, taking a mean 29% of the total dose. Injectors treating neck conditions have been putting toxin into this muscle for decades. What is new is doing it to change how a shoulder looks. See the therapeutic uses page for the full set of approved indications.
4. What the label says about the neck
This is the part worth reading twice, because the label's language about neck injection is more severe than anything in its cosmetic sections. Quoting directly:
There have been postmarketing reports of serious breathing difficulties, including respiratory failure.
And on managing that risk:
- A stated dose limit on a neighbouring muscle. The label says limiting the total dose into the sternocleidomastoid to "100 Units or less may decrease the occurrence of dysphagia", which is difficulty swallowing.
- Smaller necks carry more risk. Patients with smaller neck muscle mass, and those needing injections into both sternocleidomastoids, "have been reported to be at greater risk for dysphagia".
- The muscle directly beneath the upper trapezius is named specifically. The label states that injections into the levator scapulae "may be associated with an increased risk of upper respiratory infection and dysphagia". The levator scapulae sits under the upper trapezius, which makes depth and placement in this area a matter of anatomy rather than eyeballing.
None of that says trapezius injection is unsafe. It says the neck is a region where the label expects the injector to know precisely which muscle they are in and how deep. That is an argument about who holds the syringe, not about the treatment existing. Our guide on verifying an injector's licence covers how to check who is treating you.
5. The 400 unit ceiling, and why it matters here
The label sets a hard cumulative limit:
In treating adult patients for one or more indications, the maximum cumulative dose should not exceed 400 Units, in a 3-month interval.
Read "one or more indications". The ceiling is across everything you receive, not per area. That matters more for the trapezius than for most cosmetic targets, because it is a large muscle and doses discussed for it are correspondingly large. If you also have your forehead and frown lines done, and perhaps masseters, those units all count toward the same 400.
Ask for your total across every area, in units, for the three-month window. Any injector working properly will have that number to hand.
6. What it does and does not change
- It relaxes a muscle. If your shoulder slope is largely a bulky, overactive upper trapezius, softening it can visibly change the line.
- It will not change your skeleton. Shoulder width and the slope of the clavicles are bone. A relaxed trapezius does not move them.
- It will not help if the muscle is not the problem. Posture, body composition and build all shape that area. Toxin only addresses the muscle.
- The trapezius does real work. It elevates and stabilises the shoulder girdle. Weakening it has functional consequences worth discussing if you lift, swim, carry children or do overhead work. This is not the frontalis, where the only job is raising an eyebrow.
- It is temporary. Toxin effects on muscle wear off over months, so this is a repeating commitment at a dose that is not small.
7. What to ask before you agree
- How many units, and what is my three-month total across all areas? The ceiling is 400 units cumulative.
- Which muscle, and at what depth? The label names the levator scapulae as carrying added risk. You want an injector who volunteers that distinction rather than one you have to prompt.
- Do you tell patients this is off label? A clinic that says so unprompted is telling you something good about how it handles the rest of the conversation.
- What happens to my shoulder function? Especially if you train, swim or lift.
- What are the swallowing and breathing warning signs? The label's boxed warning covers difficulty swallowing and breathing, reported hours to weeks after injection, and says these can be life threatening. You should be told what to watch for and who to call.
If your concern is the vertical cords that stand out when you tense your neck rather than the shoulder slope, that is a different treatment with its own labelled dose, covered on the platysmal bands page.




